Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them
1 Details of the person discharging
managerial responsibilities / person
closely associated
a) Name Jennifer Harries
2 Reason for the notification
a) Position/status Non-executive Director
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission
allowance market participant, auction
platform, auctioneer or auction monitor
a) Name The Biotech Growth Trust PLC
b) LEI 549300Z41EP32MI2DN29
4 Details of the transaction(s): section
to be repeated for (i) each type of
instrument; (ii) each type of
transaction; (iii) each date; and (iv)
each place where transactions have been
conducted
a) Description of the financial Ordinary 25p sharesGB0000385517
instrument, type of instrument
Identification code
b) Nature of the transaction Acquisition of Shares
c) Price(s) and volume(s)
Price(s)
Volume(s)
1353.5989 pence per share 750
shares
d) Aggregated information - Aggregated 750 ordinary 25p shares
volume - Price
1353.5989 pence per share
e) Date of the transaction 20 November 2026
f) Place of the transaction London Stock Exchange (XLON)
Name of authorised official of issuer responsible for making notification:
Katherine Manson, for and on behalf of Frostrow Capital LLP
Company Secretary to THE BIOTECH GROWTH TRUST PLC
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/the-biotech-growth-trust-plc/r/director-pdmr-shareholding,c4427547The Biotech Growth Trust PLC - Director/PDMR Shareholding
Summary by 6ix AI
Jennifer Harries, a non-executive director of The Biotech Growth Trust PLC, bought 750 ordinary 25p shares on November 20, 2026 at 1353.5989 pence per share.
Key details
- The purchase took place on the London Stock Exchange.
- The filing is an initial notification of a transaction by a person discharging managerial responsibilities, meaning a director or senior manager whose share dealings must be disclosed.
- Frostrow Capital LLP, the company secretary, made the notification on behalf of the trust.
6ix AI wrote this summary from the release below and checked it against the release.
Biotech Growth Trust PLC on 6ix
Story so far
Earlier from Biotech Growth Trust
- Net Asset Value(s)
- Half-year Financial Report
- The Biotech Growth Trust PLC - Monthly Fact Sheet as at 31 October 2026
- The Biotech Growth Trust PLC - Transaction in Own Shares
Follow Biotech Growth Trust into a list and get an email when it puts out news.
Follow Biotech Growth Trust